It is not possible to establish to what extent the normal development of the CIPA patient described here is related to the nature of the NTRK1 mutations identified, to her early diagnosis, or to a combination of both factors. Here, NTRK1 is linked to hereditary sensory and autonomic neuropathy type 4.